Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121162322 | 12116232 | 2 | F | 2015 | 20151009 | 20160225 | 20160728 | PER | US-MYLANLABS-2015M1035422 | MYLAN | 0.00 | F | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121162322 | 12116232 | 1 | PS | Metoprolol Tartrate Tablets USP | METOPROLOL TARTRATE | 1 | Oral | 12.5 MG, BID | 76704 | 12.5 | MG | TABLET | BID | ||||||
| 121162322 | 12116232 | 2 | SS | Metoprolol Tartrate Tablets USP | METOPROLOL TARTRATE | 1 | 76704 | TABLET | |||||||||||
| 121162322 | 12116232 | 3 | SS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | 75 ?G, QD M-F | N | 0 | 75 | UG | TABLET | QD | ||||||
| 121162322 | 12116232 | 4 | SS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | 75 ?G, QD M-F | N | 0 | 75 | UG | TABLET | QD | ||||||
| 121162322 | 12116232 | 5 | SS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | Oral | 37.5 MG ON SATURDAYS | N | 0 | 37.5 | MG | TABLET | ||||||
| 121162322 | 12116232 | 6 | SS | LIOTHYRONINE SODIUM. | LIOTHYRONINE SODIUM | 1 | Oral | 5 ?G, BID | 0 | 5 | UG | TABLET | BID | ||||||
| 121162322 | 12116232 | 7 | SS | LIOTHYRONINE SODIUM. | LIOTHYRONINE SODIUM | 1 | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121162322 | 12116232 | 1 | Heart rate |
| 121162322 | 12116232 | 2 | Off label use |
| 121162322 | 12116232 | 3 | Hypothyroidism |
| 121162322 | 12116232 | 6 | Hypothyroidism |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121162322 | 12116232 | Alopecia | |
| 121162322 | 12116232 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121162322 | 12116232 | 1 | 2013 | 0 | ||
| 121162322 | 12116232 | 3 | 201508 | 0 | ||
| 121162322 | 12116232 | 4 | 20120330 | 201508 | 0 | |
| 121162322 | 12116232 | 5 | 20150330 | 201508 | 0 | |
| 121162322 | 12116232 | 6 | 201409 | 0 |